|
TMEM184C expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.39728245535298E-14 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.52571355128384E-14 |
| Normal-vs-Stage2 |
5.867395458381E-11 |
| Normal-vs-Stage3 |
1.63302704692114E-12 |
| Normal-vs-Stage4 |
1.62458935193399E-12 |
| Stage1-vs-Stage2 |
2.374400E-01 |
| Stage1-vs-Stage3 |
1.751170E-01 |
| Stage1-vs-Stage4 |
3.030700E-04 |
| Stage2-vs-Stage3 |
6.438300E-02 |
| Stage2-vs-Stage4 |
7.978000E-04 |
| Stage3-vs-Stage4 |
7.046000E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.73194791841524E-14 |
| Normal-vs-AfricanAmerican |
1.65822910958013E-12 |
| Normal-vs-Asian |
1.54587453948807E-12 |
| Caucasian-vs-AfricanAmerican |
6.093600E-01 |
| Caucasian-vs-Asian |
3.646800E-01 |
| AfricanAmerican-vs-Asian |
2.700200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.63569158218024E-12 |
| Normal-vs-Female |
5.61772850460329E-14 |
| Male-vs-Female |
3.538800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.6610046671417E-12 |
| Normal-vs-Age(41-60Yrs) |
5.06261699229071E-14 |
| Normal-vs-Age(61-80Yrs) |
1.88737914186277E-14 |
| Normal-vs-Age(81-100Yrs) |
1.611590E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.039000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.977200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.021800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.196400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.924800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.118400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.54450000000273E-05 |
| Classical-VS-Follicular |
1.706580E-01 |
| Classical-VS-Other |
2.858800E-01 |
| Classical-VS-Normal |
1.91624494050302E-12 |
| Tall-VS-Follicular |
3.63920000000517E-05 |
| Tall-VS-Other |
7.341200E-01 |
| Tall-VS-Normal |
1.62458935193399E-12 |
| Follicular-VS-Other |
1.692430E-01 |
| Follicular-VS-Normal |
1.67139635465219E-11 |
| Other-VS-Normal |
1.026490E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.81219492137552E-13 |
| Normal-vs-N1 |
9.99200722162641E-16 |
| N0-vs-N1 |
6.038500E-03 |
|
|
